18G与20G超声引导细针穿刺检测头颈部鳞状细胞癌放化疗后持续性淋巴结转移的准确性比较
该研究纳入2002至2023年间239例经活检证实颈部淋巴结转移并接受放化疗的头颈部鳞状细胞癌患者,放化疗后对可疑淋巴结残留行18G或20G超声引导细针穿刺,并与术后病理或至少3个月CT随访对照。18G组穿刺次数显著少于20G组,且特异度更高,总体穿刺准确率较高。
要点
- 放化疗后颈部淋巴结残留行超声引导细针穿刺的阴性预测值达97.8%,有助于避免不必要的颈清扫。
- 18G组特异度95.9%、准确率95.7%,均高于20G组的81.9%和84.2%。
- 18G组穿刺次数1.26±0.51次,少于20G组的1.36±0.52次(P=.037)。
核心结论
- 放化疗后残留颈部淋巴结行超声引导细针穿刺准确性高,阴性预测值优异;与20G相比,18G穿刺次数显著更少且特异度更高。
研究设计与样本
- 单中心回顾性队列研究,纳入2002至2023年间239例经活检证实颈部淋巴结转移并接受放化疗的头颈部鳞状细胞癌患者(210例男性,年龄60.4±9.8岁);101例使用20G针活检,138例使用18G针活检;以活检后手术病理结果或至少3个月CT随访作为参考标准。
诊断标准与关键数值
- 总体超声引导细针穿刺敏感度90.9%、特异度90.8%、准确率90.8%、阳性预测值69.0%、阴性预测值97.8%;20G组敏感度89.7%、特异度81.9%、准确率84.2%、阳性预测值66.7%、阴性预测值95.2%;18G组敏感度93.3%、特异度95.9%、准确率95.7%、阳性预测值73.7%、阴性预测值99.2%。
临床应用与阅片要点
- 放化疗后对可疑颈部淋巴结残留行超声引导细针穿刺可提供较高的阴性预测值,18G针穿刺次数更少且特异度更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Viable malignant disease is uncommon in patients with persistent adenopathy after definitive chemoradiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Preoperative ultrasound-guided fine-needle aspiration (USFNA) can prevent unnecessary neck dissection. Postradiation fibrosis can complicate the approach, resulting in an inadequate aspirate volume when using standard 20- or 22-gauge needles. We assessed the comparative 18- and 20-gauge diagnostic accuracy of USFNA in detecting persistent viable nodal malignancy in patients with HNSCC with nodal metastasis treated with CRT. We hypothesized that 18-gauge USFNA would outperform 20-gauge USFNA in diagnostic accuracy and efficiency.
MATERIALS AND METHODS: We identified a 239-patient cohort (210 men, 60.4 ± 9.8 years) presenting between 2002-2023 with HNSCC and biopsy-proved cervical nodal metastases. All patients were treated with CRT. After CRT, a suspicious nodal remnant underwent biopsy with an 18- or 20-gauge needle. A total of 101 patients received a biopsy with a 20-gauge and 138 received a biopsy with an 18-gauge needle. Biopsy results were compared with either postbiopsy surgical pathology results when available or at least 3 months of CT follow-up, referred to here as post-USFNA results.
RESULTS: Fine-needle aspiration (FNA) in 181 of 239 (75.7%) cases showed no evidence of viable metastatic disease on cytology evaluation. Twenty-gauge cases were performed with 1.36 ± 0.52 passes. Eighteen-gauge cases were performed with 1.26 ± 0.51 passes (P = .037). A neck dissection was performed within 90 days in 45 patients, while the other 194 patients had follow-up imaging. Forty/58 cases were positive concordant between FNA and post-USFNA results. Of 181 cases, 177 were negative concordant between FNA and post-USFNA results. Overall, USFNA showed a sensitivity of 90.9%, specificity of 90.8%, accuracy of 90.8%, positive predictive value (PPV) of 69.0%, and negative predictive value (NPV) of 97.8%. Twenty-gauge FNA showed positive concordant of 26 of 39 and negative concordant of 59 of 62 for a sensitivity of 89.7%, specificity of 81.9%, accuracy of 84.2%, PPV of 66.7%, and NPV of 95.2% Eighteen-gauge FNA showed a positive concordant of 14 of 19 and negative concordant of 118 of 119 for a sensitivity of 93.3%, specificity of 95.9%, accuracy of 95.7%, PPV of 73.7%, and NPV of 99.2%.
CONCLUSIONS: Residual cervical lymph node USFNA after CRT is an accurate procedure with excellent PPV and NPV. Eighteen-gauge USFNA is associated with statistically significant fewer biopsy passes and higher specificity compared with 20-gauge.
引用
- Nguyen J, Patel D, Lano K, et al. Comparative Accuracy of 18-Gauge versus 20-Gauge Ultrasound-Guided Fine-Needle Aspiration in the Detection of Persistent Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma after Chemoradiation. AJNR Am J Neuroradiol. 2026. PMID: 40876946. doi:10.3174/ajnr.A8990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。